Characterization of the Pharmaceutical Risk-Sharing Arrangement Process in Catalonia

Pharmaceutical risk-sharing arrangements have emerged as a reasonable tool to promote sustainable access to innovative medicines with uncertain clinical evidence and/or economic impact from the payer perspective. These funding mechanisms pose an alternative option to the traditional fixed-price meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes-Travé, Anna, Guarga-Solé, Laura, Roig-Izquierdo, Marta, Alonso-Pérez, Enrique, Clopés-Estela, Ana, Delgadillo-Duarte, Joaquín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Practical Application
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352806/
https://www.ncbi.nlm.nih.gov/pubmed/34109568
http://dx.doi.org/10.1007/s40273-021-01046-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352806/
https://www.ncbi.nlm.nih.gov/pubmed/34109568
http://dx.doi.org/10.1007/s40273-021-01046-1

Ejemplares similares